Dental ImplantsNCT02139748
The Clinical Effect of Implant Placement With a Simultaneous Soft Tissue Allograft
A study testing Dental Implant & ADM and Dental Implant & ADM & bone xenograft in people with Dental Implants, run by University of Louisville at 1 site in United States.
Trial summary
Dental implant placement and simultaneous grafting using one layer gum graft will result in the same facial ridge contour and soft tissue thickness as one layer of gum graft plus bone graft. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Dental Implants
- What is being tested?
- Dental Implant & ADM and Dental Implant & ADM & bone xenograft
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteUnited States
- Study dates
- Jul 2014to May 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Have one edentulous site bordered by 2 teeth in maxillary sites from second premolar to second premolar (maxillary 4 to 13) to receive an implant with simultaneous grafting with an ADM with or without bovine-derived xenograft.
- Healthy persons at least 18 years old.
- Understands and has signed the informed consent.
Who cannot join
- Patients with uncontrolled diabetes, immune disease, or any systemic disease that significantly affects the periodontium.
- Previous head and neck radiation.
- Patients who have taken oral bisphosphonates for > 3 years or any IV bisphosphonates.
- Smokers (or other tobacco habits that might interfere with soft tissue healing).
- Patients who need prophylactic antibiotics prior to dental procedures.
- Patients with allergies to any medication or material used in the study, or that would adversely affect study procedures.
Show all 15Show fewer
- Chemotherapy in the previous 12 months.
- Psychological problems that would interfere with treatment.
- Patients unable or unwilling to sign the informed consent.
- Pregnant subjects will be excluded due to risk of miscarriage.
- Post-treatment Exclusion Criteria
- Failure of patient to follow treatment protocol.
- Failure of implant to osseointegrate.
- Failure of the allograft to heal.
- Unanticipated healing complications that will adversely affect treatment results.
Trial locations and contacts
1 site in 1 country.
United States1 site
Graduate Periodontics, University of Louisville School of Dentistry
Louisville, Kentucky, 40292
About this study
Official title: The Clinical Effect of Implant Placement and Simultaneous Grafting Using Acellular Dermal Matrix Allograft vs. Acellular Dermal Matrix Allograft Plus Bovine-Derived Xenograft
Dental implant placement and simultaneous grafting using one layer gum graft will result in the same facial ridge contour and soft tissue thickness as one layer of gum graft plus bone graft.
Read the detailed description
30 patients will have a dental implant placed in maxillary sites from teeth number 4 to 13. Any implant system is acceptable since the objective of the study is to evaluate soft tissue thickness due to graft placement, not to evaluate the implant. 15 patients will be randomly selected by a coin toss to receive a one layer of ADM (Control Group) while another fifteen will receive one layer of ADM and bovine-derived xenograft (Test Group). The graft will be placed simultaneously with the dental implant. A blinded examiner will be used. Should the examiner become unblinded the subject will be excluded from the study.
Each patient will receive a diagnostic work-up including standardized radiographs (periapicals), study casts, clinical photographs, and a periodontal examination. Presurgical preparation will include detailed oral hygiene instructions. Baseline data will be collected at initial exam. Parameters measured will include: plaque index, gingival index, probing depth, keratinized tissue, bleeding on probing, adjacent tooth recession, radiographic examination, tissue esthetics, colors, contours, and clinical photographs will be taken at baseline, during surgery and post-op visits.
The treatment will be randomly assigned using a coin toss. The mentor will flip the coin. The surgical procedure will consist of the reflection of full thickness flaps to expose the buccal crest. A dental implant will be placed in the edentulous site. Any implant system will be acceptable since the objective of the study is to evaluate soft tissue thickness and contour, not the dental implant. Either one layer of ADM or one layer of ADM plus bovine-derived xenograft (BX) will be placed following implant placement on the buccal aspect of the implant. When one layer of ADM is used it will be placed on the buccal surface of the implant only. When one layer of ADM and BX are used the BX will be overlaid buccal to the implant, then covered by ADM. Thus the buccal surface will have either one layer of ADM or one layer of ADM with BX. The surgical procedures will be documented with clinical photographs. Records will be kept of healing every 2 weeks for the first 8 weeks, then at 4 months or 16 weeks. At the end of 16 weeks or 4 months, once the study is completed, post and crown procedure over the implant can be started.
To provide adequate room to establish emergence profile the implant platform should be 3 to 4 mm apical to the mid-facial gingival margin when a 2-stage dental implant system is used. This may require reduction of the osseous crest by scalloping the bone so that the mid-facial osseous crest is 3-4 mm apical to the mid-facial gingival margin. This may result in a sub-crestal position of the interproximal implant platform (measured as a negative number). The top of the implant will be even with the crestal bone. The implant used will be any dental implant. At the time of surgery the implant platform will be placed even with the mid-facial osseous crest if a two-stage implant is used.
All probing measurements will be taken using the University of North Carolina probe. One investigator who is unaware of group assignment will perform all baseline examinations and all follow-up examinations. He will be calibrated prior to study initiation to assure that evaluations are consistent. The surgeon will perform all surgical procedures and will know the group to which each participant has been assigned. Standardized periapical radiographs will be taken at implant placement and at the 4-month examinations.
All patients will be seen at 1-2, 3-4, 5-6 and 7-8, and 16 weeks and buccal, occlusal and lingual clinical photographs will be taken at each visit. Patients will take doxycycline hyclate 100 mg qd for two weeks, Vicodin ES q4-6h as needed for pain, and naproxen 375 mg q12h for one week for inflammation. At post-operative visits plaque removal, and oral hygiene instruction, as needed, will be performed along with clinical photographs and standardized radiographs as scheduled.
- Conditions
- Dental Implants
- Being tested
- Dental Implant & ADM, Dental Implant & ADM & bone xenograft
- Keywords
- Dental Implants, Alveolar Bone Grafting, Acellular Dermis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dental Implant & ADMProcedure or surgery
A dental implant will be placed and the buccal soft tissue will be grafted using an acellular dermal matrix allograft.
Dental Implant & ADM & bone xenograftProcedure or surgery
A dental implant will be placed along with a buccal acellular dermal matrix allograft which will cover a bone xenograft.
| Study group | Role | What they receive |
|---|---|---|
| Dental Implant & ADM | Active comparator | Dental implant placement plus simultaneous grafting use one layer of ADM. Receives: Procedure: Dental Implant & ADM |
| Dental Implant & ADM & bone xenograft | Experimental | Dental implant placement plus simultaneous grafting use one layer of ADM with bovine xenograft. Receives: Procedure: Dental Implant & ADM; Procedure: Dental Implant & ADM & bone xenograft |
What is being measured
The primary outcome is the main question the study is designed to answer.
Buccal soft tissue contour around dental implant.
Contour will be categorized as concave, flat, or convex (subjective categories).
Measured: 4 months post dental implant placement.
Secondary outcomes (2)
Buccal soft tissue thickness around dental implant.
Thickness will be measured with an endodontic file using a rubber stopper (objective measure of tissue thickness by penetrating tissue and measuring the thickness in mm).
Measured: 4 months post dental implant placement.
Buccal soft tissue healing around dental implant.
The outcomes will be categorized as normal, delayed or accelerated (subjective assessment and assignment to a category).
Measured: 4 months post dental implant placement.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 May 2014 (estimated)
- Study startJul 2014
- Primary completionMay 2015
- Study completionMay 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dental ImplantsStudies of the same condition, open and under way.
- More trials run by University of LouisvilleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Louisville
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Henry Greenwell, University of Louisville
- Investigators
- Ting-wei H Hsu, D.M.D, Study director, Co-investigator, University of LouisvilleHenry Greenwell, D.M.D, M.S.D, Principal investigator, University of LouisvilleBobby L Cockerham, DDS, Study director, Co-investigator University of Louisville
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02139748
- Sponsor's protocol ID
- 14.0387
- Status last verified
- May 2014
- First submitted
- 25 Apr 2014
- Last updated
- 8 Dec 2016
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 8 Dec 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Clinical Effect of Implant Placement and Simultaneous Grafting Using Acellular Dermal Matrix Allograft vs. Acellular Dermal Matrix Allograft Plus Bovine-Derived Xenograft
- ClinicalTrials.gov ID
- NCT02139748
- Acronym / sponsor ID
- 14.0387
- Conditions
- Dental Implants
- Keywords
- Dental Implants, Alveolar Bone Grafting, Acellular Dermis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 28 participants (actual)
- Lead sponsor
- University of LouisvilleUniversity, hospital or other
- Study start
- Jul 2014
- Primary completion
- May 2015 (actual)
- Study completion
- May 2015 (actual)
- First posted
- 15 May 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Dental implant placement and simultaneous grafting using one layer gum graft will result in the same facial ridge contour and soft tissue thickness as one layer of gum graft plus bone graft.
Detailed description
30 patients will have a dental implant placed in maxillary sites from teeth number 4 to 13. Any implant system is acceptable since the objective of the study is to evaluate soft tissue thickness due to graft placement, not to evaluate the implant. 15 patients will be randomly selected by a coin toss to receive a one layer of ADM (Control Group) while another fifteen will receive one layer of ADM and bovine-derived xenograft (Test Group). The graft will be placed simultaneously with the dental implant. A blinded examiner will be used. Should the examiner become unblinded the subject will be excluded from the study.
Each patient will receive a diagnostic work-up including standardized radiographs (periapicals), study casts, clinical photographs, and a periodontal examination. Presurgical preparation will include detailed oral hygiene instructions. Baseline data will be collected at initial exam. Parameters measured will include: plaque index, gingival index, probing depth, keratinized tissue, bleeding on probing, adjacent tooth recession, radiographic examination, tissue esthetics, colors, contours, and clinical photographs will be taken at baseline, during surgery and post-op visits.
The treatment will be randomly assigned using a coin toss. The mentor will flip the coin. The surgical procedure will consist of the reflection of full thickness flaps to expose the buccal crest. A dental implant will be placed in the edentulous site. Any implant system will be acceptable since the objective of the study is to evaluate soft tissue thickness and contour, not the dental implant. Either one layer of ADM or one layer of ADM plus bovine-derived xenograft (BX) will be placed following implant placement on the buccal aspect of the implant. When one layer of ADM is used it will be placed on the buccal surface of the implant only. When one layer of ADM and BX are used the BX will be overlaid buccal to the implant, then covered by ADM. Thus the buccal surface will have either one layer of ADM or one layer of ADM with BX. The surgical procedures will be documented with clinical photographs. Records will be kept of healing every 2 weeks for the first 8 weeks, then at 4 months or 16 weeks. At the end of 16 weeks or 4 months, once the study is completed, post and crown procedure over the implant can be started.
To provide adequate room to establish emergence profile the implant platform should be 3 to 4 mm apical to the mid-facial gingival margin when a 2-stage dental implant system is used. This may require reduction of the osseous crest by scalloping the bone so that the mid-facial osseous crest is 3-4 mm apical to the mid-facial gingival margin. This may result in a sub-crestal position of the interproximal implant platform (measured as a negative number). The top of the implant will be even with the crestal bone. The implant used will be any dental implant. At the time of surgery the implant platform will be placed even with the mid-facial osseous crest if a two-stage implant is used.
All probing measurements will be taken using the University of North Carolina probe. One investigator who is unaware of group assignment will perform all baseline examinations and all follow-up examinations. He will be calibrated prior to study initiation to assure that evaluations are consistent. The surgeon will perform all surgical procedures and will know the group to which each participant has been assigned. Standardized periapical radiographs will be taken at implant placement and at the 4-month examinations.
All patients will be seen at 1-2, 3-4, 5-6 and 7-8, and 16 weeks and buccal, occlusal and lingual clinical photographs will be taken at each visit. Patients will take doxycycline hyclate 100 mg qd for two weeks, Vicodin ES q4-6h as needed for pain, and naproxen 375 mg q12h for one week for inflammation. At post-operative visits plaque removal, and oral hygiene instruction, as needed, will be performed along with clinical photographs and standardized radiographs as scheduled.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Dental Implant & ADM | Active comparator | Procedure: Dental Implant & ADMDental implant placement plus simultaneous grafting use one layer of ADM. |
| Dental Implant & ADM & bone xenograft | Experimental | Procedure: Dental Implant & ADM, Procedure: Dental Implant & ADM & bone xenograftDental implant placement plus simultaneous grafting use one layer of ADM with bovine xenograft. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Have one edentulous site bordered by 2 teeth in maxillary sites from second premolar to second premolar (maxillary 4 to 13) to receive an implant with simultaneous grafting with an ADM with or without bovine-derived xenograft.
- Healthy persons at least 18 years old.
- Understands and has signed the informed consent.
Key exclusion criteria (15 listed)
- Patients with uncontrolled diabetes, immune disease, or any systemic disease that significantly affects the periodontium.
- Previous head and neck radiation.
- Patients who have taken oral bisphosphonates for > 3 years or any IV bisphosphonates.
- Smokers (or other tobacco habits that might interfere with soft tissue healing).
- Patients who need prophylactic antibiotics prior to dental procedures.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dental Implant & ADMA dental implant will be placed and the buccal soft tissue will be grafted using an acellular dermal matrix allograft. | Procedure or surgery | Dental Implant & ADM, Dental Implant & ADM & bone xenograft |
| Dental Implant & ADM & bone xenograftA dental implant will be placed along with a buccal acellular dermal matrix allograft which will cover a bone xenograft. | Procedure or surgery | Dental Implant & ADM & bone xenograft |
Primary outcome
Buccal soft tissue contour around dental implant.
Time frame: 4 months post dental implant placement.
Contour will be categorized as concave, flat, or convex (subjective categories).
2 secondary outcomes
Buccal soft tissue thickness around dental implant.
Time frame: 4 months post dental implant placement.
Buccal soft tissue healing around dental implant.
Time frame: 4 months post dental implant placement.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Dec 2016.
Related trials for Dental Implants
Not yet recruiting
Free Soft Tissue Grafts (FSTG) Using Autograft Palatal Donor Tissue vs. Xenograft Collagen Matrix (Zderm™)
Gingival Recession Localized Moderate, Dental Implant
Not yet recruiting
Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot Study
Tooth Loss and Rehabillitation, Dental Implant Failure
Active, not recruiting
L-PRF Block vs Composite Graft for Horizontal Ridge Augmentation
Alveolar Ridge Resorption After Extraction, Alveolar Bone Loss
RecruitingObservational study
Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants
Dental Implants
Active, not recruiting
The Aim of the Study Will be Clinically and Radio Graphically Comparison of Two Implant Designs Used to Treat Atrophied Mandible . Implant Design Comparison Will Done for Implant Stability,Peri-implant Soft Tissue Health Changes and Bone Changes .Patients Will be Divided Randomly Into Two Group
Dental Implant Bone Loss, Peri-Implant Health
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ting-wei H Hsu, D.M.D study director
Co-investigator, University of Louisville
Henry Greenwell, D.M.D, M.S.D principal investigator
University of Louisville
Bobby L Cockerham, DDS study director
Co-investigator University of Louisville
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dental Implant & ADM and Dental Implant & ADM & bone xenograft in people with Dental Implants, run by University of Louisville at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Buccal soft tissue contour around dental implant. (time frame: 4 months post dental implant placement.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2016.